A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.

Miriam W. Tsao,Sylvie D. Cornacchi,Nicole Hodgson,Marko Simunovic,Lehana Thabane,Ji Cheng,Mary Ann O’Brien,Barbara Strang,Som D. Mukherjee,Peter J. Lovrics

Annals of surgical oncology（2016）

引用 20|浏览3

暂无评分

摘要

Evidence from the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial suggests completion axillary lymph node dissection (cALND) after positive sentinel lymph node biopsy (+SLNB) does not improve outcomes in select patients, leading to practice variation. A multidisciplinary group of surgeons, oncologists, and pathologists developed a regional guideline for cALND which was disseminated in August 2012. We assessed the impact of Z0011 and the regional guideline on cALND rates.

查看译文

关键词

Breast Cancer,Sentinel Lymph Node Biopsy,Axillary Lymph Node Dissection,Lymph Node Ratio,Positive Sentinel Lymph Node

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要